Overview
honey is a natural functional food used in control cardiovascular risk factors but its effect on fatty liver is not investigated
Description
Forty fatty liver (non-alcoholic from) patients with obesity are included to be divided into group 1 who will contain 20 patients who will receive honey intake (orally, as a daily total dose of 2 g/kg, this dose will be divided to three equal subdoses, every dose will be administered before meal), low calorie diet, and treadmill walking (40 minutes per session, three times per week) for 12 weeks. Group 2 who will contain 20 patients who will receive low calorie diet, and treadmill walking (40 minutes per session, three times per week) for 12 weeks.
Eligibility
Inclusion Criteria:
- fatty liver (non alcoholic form)
- both sexes included
- obese subjects (class I)
Exclusion Criteria:
- cardiac insult
- respiratory insult
- renal insult
- lower limb insult